We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TRIB market cap is 23.47M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.04M | 14.83M | 13.9M | 14.68M | 13.43M |
| Operating Income | -1.98M | -3.92M | -4.04M | -4.65M | -3.34M |
| Net Income | -10.08M | -5.81M | -5.99M | -6.72M | -5.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 90.44M | 101.98M | 92.97M | 74.78M | 56.83M |
| Operating Income | -22.9M | 17.86M | 6.42M | -16.34M | -15.94M |
| Net Income | -28.91M | -6.39M | 875k | -41.01M | -24.02M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.1M | 91.16M | 71.99M | 63.6M | 59.44M |
| Total Liabilities | 94.28M | 97.78M | 83.37M | 81.08M | 83.38M |
| Total Equity | -2.18M | -6.62M | -11.38M | -17.49M | -23.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 131.07M | 130.4M | 118.9M | 92.1M | 59.44M |
| Total Liabilities | 126.36M | 132.62M | 119.21M | 94.28M | 83.38M |
| Total Equity | 4.71M | -2.22M | -319k | -2.18M | -23.95M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -921k | -2.72M | -7.14M | -11.8M | -11.56M |
| Investing | -5.98M | -1.33M | 26.53M | 25.65M | 24.76M |
| Financing | -12.32M | 1.61M | -11.85M | -14.28M | -16.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.42M | 23.76M | 13.24M | -921k | -11.56M |
| Investing | -11.85M | -10.2M | -8.69M | -5.98M | 24.76M |
| Financing | -7.53M | -2.72M | -6.02M | -12.32M | -16.04M |
| Market Cap | 23.47M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 9.47M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.97 (29.66%) |
| Company Name | Trinity Biotech PLC |
| Address |
ida business park wicklow A98 H5C8 |
| Website | https://www.trinitybiotech.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
